Illinois Tool Works Inc. · ITW · FY2026 Q2 · Calendar Q3 2026

ITW raises 2026 outlook as CapEx demand and innovation accelerate

The supplied analysis supports a constructive but conditional view: ITW's raised guidance, CapEx-led demand, and Customer-Backed Innovation provide evidence for continued growth, while price-cost timing, capacity, and demand durability remain important tests.

Reported Before market openNYSEIndustrials $77.81B market cap
100quality score

Earnings scorecard

Reported versus consensus
Reported EPS $2.84 Consensus $2.79
EPS surprise +1.8% Reported versus consensus
Reported revenue $4.30B Consensus $4.19B
Revenue surprise +2.7% Reported versus consensus

Market reaction

prior-close to event-session close
Stock move +3.6% Event window
SPY move +0.2% Same window
Abnormal move +3.4% Stock minus SPY
Volume 2.0× Versus trailing sessions
Subsequent drift -4.6% Up to 20 sessions
ITWSPY benchmark

Ask FN2 about ITW FY2026 Q2

Transcript, numbers and history already loaded

Free account. Your question opens in FN2 with this report's transcript and numbers attached.

Transcript intelligence

What changed

Compared with the prior quarter, management reported faster organic growth, higher full-year guidance, and stronger evidence that Customer-Backed Innovation is contributing to revenue. The emphasis also shifted toward proactive capacity investment as demand accelerated.

Guidance delta

Management raised full-year guidance to 3.5% organic growth at the midpoint and GAAP EPS of $11.45.

Key takeaways

  • Organic growth accelerated to 4.5% in Q2, led by CapEx-focused segments.
  • Customer-Backed Innovation contributed 3% to first-half revenue growth, above expectations.
  • Operating margin expanded to 26.7% despite a temporary price/cost timing lag.
  • Management said demand is strong in infrastructure, energy, aerospace, defense, and EV markets.

Management priorities

  • Expand Customer-Backed Innovation and the new-product pipeline.
  • Invest proactively in semiconductor and electronics capacity.
  • Pursue disciplined, high-margin bolt-on acquisitions.
  • Continue margin improvement and the approximately $1.5 billion FY2026 share-repurchase program.

Follow ITW with an agent that reads every filing, transcript, and price print. Free to start.

Try FN2 free

Earnings History

Estimate Beat Miss Match
ITW EPS earnings history estimate and actual scatter chart 9 reported fiscal quarters and 3 future estimate-only quarters. Q1 '24 estimate $2.36 Q1 '24 actual $2.44, beat Q2 '24 estimate $2.48 Q2 '24 actual $2.54, beat Q3 '24 estimate $2.52 Q3 '24 actual $2.65, beat Q2 '25 estimate $2.56 Q2 '25 actual $2.58, beat Q3 '25 estimate $2.75 Q3 '25 actual $2.81, beat Q4 '25 estimate $2.69 Q4 '25 actual $2.72, beat Q1 '26 estimate $2.57 Q1 '26 actual $2.66, beat Q2 '26 estimate $2.79 Q2 '26 actual $2.84, beat Q3 '26 estimate $2.96 Q4 '26 estimate $2.93 Q1 '27 estimate $2.74
Show 1 more >

Analyst Consensus ?

ConsensusHold28 ratings
Bullish621.4%
Neutral1346.4%
Bearish932.2%

Analyst 52W Price Targets

$273.42Current
$187Low
$255.88Average
$301High

Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Sep 24, 2026. Not an FN2 forecast.

Firm-level rating actions

FMP grade actions identify the grading firm, not a named analyst.

FirmRatingPrior ratingActionDate
Evercore ISI Group Underperform UnderperformMaintainAug 11, 2026
JP Morgan Overweight OverweightMaintainJul 29, 2026
Baird Neutral NeutralMaintainJul 29, 2026
Truist Securities Hold HoldMaintainJul 2, 2026
Wells Fargo Underweight UnderweightMaintainMay 4, 2026
Citigroup Neutral NeutralMaintainMay 4, 2026
Barclays Underweight UnderweightMaintainApr 1, 2026
Goldman Sachs Sell NeutralDowngradeDec 16, 2025
B of A Securities Neutral UnderperformUpgradeNov 18, 2025
UBS Neutral NeutralMaintainJul 31, 2025
Stifel Hold HoldMaintainJul 31, 2025
Jefferies Hold HoldMaintainDec 6, 2024
Morgan Stanley Underweight UnderweightMaintainAug 3, 2023
Credit Suisse Outperform OutperformMaintainAug 2, 2023
Deutsche Bank Sell SellMaintainApr 12, 2023
Vertical Research Hold BuyDowngradeJan 3, 2023
BMO Capital Market Perform Market PerformMaintainMay 3, 2021
CFRA Sell SellMaintainJan 31, 2020
Stifel Nicolaus Hold HoldMaintainJul 29, 2019
Northcoast Research Sell NeutralDowngradeJun 26, 2019
Argus Research Buy BuyMaintainApr 26, 2019
Bank of America Underperform NeutralDowngradeFeb 5, 2019
Seaport Global Neutral BuyDowngradeOct 25, 2018
Argus Buy BuyMaintainMay 5, 2018
RBC Capital Perform Sector PerformMaintainNov 25, 2014
ISI Group Buy NeutralUpgradeAug 7, 2014
Tigress Financial Neutral NeutralMaintainMar 12, 2013
Barrington Research Outperform OutperformMaintainOct 24, 2012
Show less

Named analyst price targets

Upside is calculated against the persisted current price $273.42. FMP does not supply a rating on these named-analyst rows.

FirmAnalyst52W targetPrice when postedUpsideDate
UBSSteven Fisher$300$296.5 +9.7%Jul 29, 2026
Robert W. BairdAnalyst unavailable$297$295.16 +8.6%Jul 29, 2026
Wolfe ResearchNigel Coe$286$266.56 +4.6%Jul 9, 2026
Truist FinancialAnalyst unavailable$301$268.97 +10.1%Jul 2, 2026
Evercore ISIAnalyst unavailable$272$254.72 -0.5%May 11, 2026
Wells FargoJoseph O'Dea$255$255.47 -6.7%May 4, 2026
Goldman SachsAnalyst unavailable$254$258.01 -7.1%Apr 30, 2026
BarclaysJulian Mitchell$275$293.57 +0.6%Feb 9, 2026
Truist FinancialAnalyst unavailable$280$290.33 +2.4%Feb 4, 2026
UBSAnalyst unavailable$285$290.71 +4.2%Feb 4, 2026
Robert W. BairdMircea Dobre$278$278.91 +1.7%Feb 4, 2026
Wells FargoJoseph O'Dea$270$278.91 -1.3%Feb 4, 2026
Goldman SachsAnalyst unavailable$253$278.91 -7.5%Feb 3, 2026
Goldman SachsAnalyst unavailable$230$259.07 -15.9%Dec 16, 2025
Truist FinancialAnalyst unavailable$275$245.75 +0.6%Oct 27, 2025
BarclaysAnalyst unavailable$244$246.98 -10.8%Oct 27, 2025
Robert W. BairdAnalyst unavailable$265$247.12 -3.1%Oct 27, 2025
Goldman SachsAnalyst unavailable$258$247.48 -5.6%Oct 27, 2025
Wells FargoJoseph O'Dea$245$245.75 -10.4%Oct 27, 2025
Truist FinancialAnalyst unavailable$298$255.75 +9.0%Oct 8, 2025
Evercore ISIDavid Raso$265$259.22 -3.1%Aug 19, 2025
Truist FinancialAnalyst unavailable$283$253.67 +3.5%Jul 31, 2025
BarclaysAnalyst unavailable$252$255.89 -7.8%Mar 26, 2025
BarclaysJulian Mitchell$260$274.48 -4.9%Mar 10, 2025
Wells FargoJoseph O'Dea$250$248.59 -8.6%Jan 7, 2025
CFRAJonathan Sakraida$250$247.57 -8.6%Sep 10, 2024
Wells FargoJoseph O'Dea$236$249.34 -13.7%Jul 31, 2024
Truist FinancialJamie Cook$281$249.34 +2.8%Jul 31, 2024
Wells FargoJoseph O'Dea$244$244.11 -10.8%May 1, 2024
Wolfe ResearchNigel Coe$250$262.94 -8.6%Apr 8, 2024
Truist FinancialJamie Cook$303$262.67 +10.8%Mar 13, 2024
BarclaysAnalyst unavailable$172$183.33 -37.1%Oct 3, 2022
Morgan StanleyAnalyst unavailable$191$206.61 -30.1%Aug 3, 2022
Wells FargoAnalyst unavailable$187$204.9 -31.6%Aug 3, 2022
JefferiesStephen Volkmann$195$193.4 -28.7%Jul 26, 2022
BarclaysAnalyst unavailable$167$185.64 -38.9%Jul 8, 2022
Wells FargoAnalyst unavailable$185$182.99 -32.3%Jun 29, 2022
Morgan StanleyAnalyst unavailable$182$204.12 -33.4%May 31, 2022
BarclaysAnalyst unavailable$180$199.78 -34.2%May 24, 2022
UBSSteven Fuller$243$201.77 -11.1%May 21, 2022
Morgan StanleyAnalyst unavailable$187$209.05 -31.6%May 4, 2022
Credit SuisseAnalyst unavailable$261$208.85 -4.5%May 4, 2022
BarclaysAnalyst unavailable$192$204.2 -29.8%May 4, 2022
Deutsche BankNicole DeBlase$226$199.7 -17.3%May 2, 2022
Stifel NicolausNathan Jones$202$203.35 -26.1%Apr 23, 2022
BarclaysJulian Mitchell$200$206.43 -26.9%Apr 5, 2022
Credit SuisseJamie Cook$284$245.63 +3.9%Jan 13, 2022
BMO CapitalJoel Tiss$235$232.65 -14.1%Dec 2, 2021
JefferiesStephen Volkmann$260$224.16 -4.9%Oct 28, 2021
UBSSteven Fisher$253$223.32 -7.5%Aug 5, 2021
Wolfe ResearchNigel Coe$243$223.8 -11.1%Jul 12, 2021
Argus ResearchJohn Eade$260$230.68 -4.9%May 5, 2021
Show less

Track every rating change on ITW the moment it posts. Free to start.

Start free

Company context

Snapshot as of publication

Illinois Tool Works Inc. is a global enterprise specializing in the production and distribution of a wide array of industrial goods and specialized equipment. The company operates through seven distinct divisions: Automotive OEM; Food Equipment; Test & Measurement and Electronics; Welding; Polymers & Fluids; Construction Products; and Specialty Products. The Automotive OEM division supplies plastic and metal components, various fastening solutions, and integrated assemblies for automobiles, light-duty trucks, and other industrial applications. Its Food Equipment segment delivers commercial kitchen appliances for washing, refrigeration, cooking, and food processing, alongside comprehensive kitchen exhaust, ventilation, and pollution control systems, and offers related maintenance and repair services.…

Historical context

All ITW earnings

Industrials peers this season

Latest reports in the same sector

Latest beats and misses

Who reports next

Get the ITW recap when the next report posts

One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.

Sources

  1. Earnings call transcript and parsed analysis · 2026-07-28T19:05:13.361320+00:00
  2. FN2 earnings calendar · 2026-09-02T01:23:14.593608+00:00
  3. Polygon adjusted daily market bars · 2026-09-23T23:30:54.452632+00:00
  4. Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-09-23T23:30:54.449825+00:00

Methodology

Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.

Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.

Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.

By FN2 Research · Updated · As of 2026-09-23. For educational purposes only; not investment advice.